NewAmsterdam Pharma (NAMS) Treasury Shares (2022 - 2026)

NewAmsterdam Pharma (NAMS) has 5 years of Treasury Shares data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 51.78% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 51.78% YoY), and the FY2025 full-year result was $728283.0, up 409.28% from the prior year.
• Treasury Shares grew to $1.0 million in Q1 2026, from $728283.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.0 million in Q1 2026 to a low of $143002.0 in Q4 2024.
• A 5-year average of $640210.7 and a median of $621105.2 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares tumbled 76.51% in 2024 and soared 409.28% in 2025, its largest moves.
• Tracing NAMS's Treasury Shares over 5 years: stood at $621105.2 in 2022, then slipped by 1.98% to $608779.0 in 2023, then plunged by 76.51% to $143002.0 in 2024, then soared by 409.28% to $728283.0 in 2025, then surged by 38.34% to $1.0 million in 2026.
• Business Quant data shows NAMS's Treasury Shares at $1.0 million in Q1 2026, $728283.0 in Q4 2025, and $724908.0 in Q3 2025.